Key features and details
- Rabbit polyclonal to bacterial Luciferase (HRP)
- Suitable for: WB, ELISA, Immunomicroscopy
- Reacts with: Photobacterium
- Conjugation: HRP
- Isotype: IgG
Product nameAnti-bacterial Luciferase antibody (HRP)
DescriptionRabbit polyclonal to bacterial Luciferase (HRP)
Tested applicationsSuitable for: WB, ELISA, Immunomicroscopymore details
Species reactivityReacts with: Photobacterium
Luciferase from Photobacterium fischerii.
Storage instructionsShipped at 4°C. Store at +4°C.
Storage bufferPreservative: 0.01% Gentamicin sulphate
Constituents: 0.42% Potassium phosphate, 0.87% Sodium chloride, 1% BSA
Concentration information loading...
Purification notesIgG fraction purified from monospecific antiserum by a multi-step process which includes delipidation, salt fractionation and ion exchange chromatography followed by extensive dialysis against 0.02M Potassium Phosphate, 0.15M NaCl, pH 7.2.
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
- 450 nm Stop Solution for TMB Substrate (ab171529)
- 650 nm Stop Solution for TMB Substrate (ab171531)
- Immunoassay Blocking Buffer (ab171534)
- Immunoassay Blocking (BSA Free) (ab171535)
Our Abpromise guarantee covers the use of ab390 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use at an assay dependent concentration.|
|ELISA||Use at an assay dependent concentration.|
|Immunomicroscopy||Use at an assay dependent concentration.|
ab390 has been referenced in 2 publications.
- Fransson M et al. Intranasal delivery of central nervous system-retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis. Immunology 142:431-41 (2014). PubMed: 24588452
- Fransson M et al. CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery. J Neuroinflammation 9:112 (2012). PubMed: 22647574